Business
Manufacturing Agreement with Tata Chemicals
Manufacturing Agreement with Tata Chemicals.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 7814P OptiBiotix Health PLC 05 September 2017 \n \n\n \nOptiBiotix Health plc\n(\"OptiBiotix\" or \"the Company\")\n \nScale up and Manufacturing Agreement with Tata Chemicals\n \nOptiBiotix Health plc (AIM: OPTI), a life sciences business developing products to tackle obesity, high cholesterol and diabetes, announces that it has entered into a scale up and manufacturing agreement with Tata Chemicals (\"TCL\"). The Agreement grants TCL a right to scale up and exclusively manufacture galacto-oligosaccharide produced by OptiBiotix's LP-LDL® strain (LPGOS) for the use in food and Over The counter (OTC) products, subject to successful development of LPGOS at pilot level.\n \nTata Chemicals Limited (\"TCL\" or \"Tata Chemicals\"), is a global science company active in industrial chemicals, food and nutrition, and agriculture business, and is listed on the Indian stock Exchange. It is part of the Tata Group of Companies which employs over 660,000 employees with annual revenues in 2015/16 of $103.51 billion. Tata Chemicals Food and Nutrition business is a major supplier of salts, spices, and nutritional solutions to the food, beverage, nutraceutical and pharmaceutical industries within India and increasingly across global markets.\n \nThe Agreement brings together TCL's expertise in the manufacture of galacto-oligosaccharides with OptiBiotix's microbiome modulation expertise to create products which selectively modify an individual's microbiome to improve health. LPGOS has been shown in gut models to:-\n \ni. Increase the growth and biological activity of OptiBiotix's cholesterol reducing strain (LP-LDL®), leading to a threefold increase in the strains cholesterol lowering ability\n \nii. Modify an individual's existing microbiome reducing cholesterol by up 22%\n \nLPGOS is the first of a range of ingredients being developed by OptiBiotix which can modify an individual's current microbiome to improve health. OptiBiotix believes this creates opportunities to use LPGOS in a wide range of food products to help reduce cardiovascular risk factors and improve health. These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe, ingredients which modulate specifi...